Correction: Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial.
Saved in:
| Title: | Correction: Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial. |
|---|---|
| Authors: | Koda, Masao1 (AUTHOR) masaokod@gmail.com, Imagama, Shiro2 (AUTHOR), Nakashima, Hiroaki2 (AUTHOR), Ito, Sadayuki2 (AUTHOR), Segi, Naoki2 (AUTHOR), Ouchida, Jun2 (AUTHOR), Suda, Kota3 (AUTHOR), Harmon Matsumoto, Satoko3 (AUTHOR), Komatsu, Miki3 (AUTHOR), Endo, Toshiki4,5 (AUTHOR), Suzuki, Shinsuke4 (AUTHOR), Inami, Satoshi6 (AUTHOR), Ueda, Haruki6 (AUTHOR), Miyagi, Masayuki7 (AUTHOR), Inoue, Gen7 (AUTHOR), Takaso, Masashi7 (AUTHOR), Nagata, Keiji8 (AUTHOR), Yamada, Hiroshi8 (AUTHOR), Kamei, Naosuke9 (AUTHOR), Nakamae, Toshio9 (AUTHOR) |
| Source: | Stem Cell Research & Therapy. 11/6/2024, Vol. 15 Issue 1, p1-1. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17576512 |
|---|---|
| DOI: | 10.1186/s13287-024-04044-0 |
